Japan Tobacco Inc. (JT) (TSE: 2914) announces a change in executive appointment from the Board of Directors.
Koji Shimayoshi will move from his current position as Senior Vice President, Head of Tobacco Business Planning Division on September 30, 2017 and will take up his new role as Senior Vice President of JTI's (Japan Tobacco International) Executive Committee on October 1, 2017.
###
Japan Tobacco Inc. is a leading international tobacco company. Its products are sold in over 120 countries and its globally recognized brands include Winston, Camel, Mevius, LD and Natural American Spirit. With diversified operations, JT is also actively present in pharmaceuticals and processed foods. The company's revenue was ¥2.143 trillion (US$19,703 million(*)) in the fiscal year ended December 31, 2016.
*Translated at the rate of ¥108.78 per $1
Contact: Masahito Shirasu, General Manager Media and Investor Relations Division
Japan Tobacco Inc. Tokyo: +81-3-5572-4292 E-mail: jt.media.relations@jt.com
Supplementary Material
Executive Officers
As of October 1, 2017
President
Chief Executive Officer
Mitsuomi Koizumi
Executive Vice President
Deputy Chief Executive Officer,
Compliance, General Affairs, Legal, HR , Corporate Strategy, IT, Business Development and Operation Review & Business Assurance
Yasushi Shingai
Executive Vice President
President, Tobacco Business
Mutsuo Iwai
Executive Vice President
Finance, CSR and Communications
Hideki Miyazaki
Senior Vice President
Compliance and General Affairs
Ryoji Chijiiwa
Senior Vice President
President, Japanese Tobacco Business, Tobacco Business
Chito Sasaki
Senior Vice President
Head of China Division, Tobacco Business
Kazuhito Yamashita
Senior Vice President
Chief Marketing & Sales Officer, Tobacco Business
Shiroji Maeda
Senior Vice President
Corporate, Scientific & Regulatory Affairs Division, Tobacco Business
Junichi Fukuchi
Senior Vice President
Chief R&D Officer, Tobacco Business
Takehisa Shibayama
Senior Vice President
Manufacturing Group, Tobacco Business
Hirakazu Otomo
Senior Vice President
Head of Leaf Procurement Group, Tobacco Business
Kenji Ogura
Senior Vice President
Head of Quality Assurance Group, Tobacco Business
Hiroyuki Ikuma
Senior Vice President
President, Pharmaceutical Business
Muneaki Fujimoto
Senior Vice President
Head of Central Pharmaceutical Research Institute, Pharmaceutical Business
Shigenori Ohkawa
Senior Vice President
Chief Financial Officer
Naohiro Minami
Senior Vice President
CSR
Ryoko Nagata
Senior Vice President
Legal
Haruhiko Yamada
Senior Vice President
Human Resources
Kiyohide Hirowatari
Senior Vice President
Corporate Strategy and IT
Yuki Maeda
Senior Vice President
Business Development
Takehiko Tsutsui
Senior Vice President
Communications
Kei Nakano
Senior Vice President
General Affairs
Takanori Kikuchi
Japan Tobacco Inc. published this content on 15 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 15 September 2017 06:08:03 UTC.
Original documenthttps://www.jt.com/media/news/2017/pdf/20170915_E11.pdf
Public permalinkhttp://www.publicnow.com/view/8508DED24B02FB91B6833146DF753B6C5BD672B9
Japan Tobacco Inc. specializes in manufacturing and marketing of tobacco products. The group's products include primarily cigarettes, cigars, chewing and snuff tobaccos. Net sales break down by activity as follows:
- sale of tobacco products overseas (66%): 460 billion products sold in 2021, under the brands Winston, Camel, Silk Cut, Sobranie, Glamour, etc.;
- sale of tobacco products in Japan (24.1%): 67 billion products sold under the brands Cabin Prestige, Seven Stars, Pianissimo, Mild Seven, etc.;
- distribution of food products (6.3%);
- development of pharmaceutical products (3.5%): primarily for dyslipidemia, osteoporosis and Hepatitis C treatment;
- other (0.1%).
68.5% of net sales are abroad.
JAPAN TOBACCO, INC. 
